View Future GrowthCroda International 過去の業績過去 基準チェック /16Croda Internationalの収益は年間平均-22.1%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間4% 1.1%割合で 減少しています。 Croda Internationalの自己資本利益率は2.9%であり、純利益率は3.6%です。主要情報-22.15%収益成長率-22.64%EPS成長率Chemicals 業界の成長12.93%収益成長率-1.06%株主資本利益率2.94%ネット・マージン3.65%次回の業績アップデート28 Jul 2026最近の業績更新お知らせ • Dec 24+ 1 more updateCroda International Plc to Report Fiscal Year 2026 Results on Feb 23, 2027Croda International Plc announced that they will report fiscal year 2026 results on Feb 23, 2027お知らせ • Jan 22+ 1 more updateCroda International Plc to Report Fiscal Year 2025 Results on Feb 24, 2026Croda International Plc announced that they will report fiscal year 2025 results on Feb 24, 2026お知らせ • Jan 30+ 1 more updateCroda International Plc to Report First Half, 2024 Results on Jul 30, 2024Croda International Plc announced that they will report first half, 2024 results on Jul 30, 2024お知らせ • Mar 04Croda International Plc to Report Fiscal Year 2022 Results on Mar 07, 2023Croda International Plc announced that they will report fiscal year 2022 results on Mar 07, 2023すべての更新を表示Recent updatesお知らせ • Apr 25Croda International plc Approves Final DividendCroda International Plc at its AGM held on April 22, 2026 approved a final dividend of 63.0 pence per ordinary share.お知らせ • Feb 25Croda International Plc, Annual General Meeting, Apr 22, 2026Croda International Plc, Annual General Meeting, Apr 22, 2026.お知らせ • Feb 24Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2025, Payable on 27 May 2026Croda International Plc announced that the Directors are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2025. Subject to shareholder approval, the dividend will be paid on 27 May 2026 to shareholders registered on 10 April 2026. The total proposed dividend for the year ended 31 December 2025 will be 111 pence per share amounting to £154.9 million.お知らせ • Jan 09Croda International Plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026Croda International Plc announced the appointment of Jill Anderson as a Non-Executive Director. Jill will join the Board on January 12, 2026 and become a member of the Audit, Nomination and Remuneration Committees. Jill brings more than 30 years' experience in international leadership positions in the healthcare industry, including executive responsibility in finance, commercial research and supply chain functions. Most recently, Jill was Chief Financial Officer of GSK's R&D division until she retired in 2024. Jill is currently a Non-Executive Director and Audit Committee Chair at Spire Healthcare Group plc.お知らせ • Dec 24+ 1 more updateCroda International Plc to Report Fiscal Year 2026 Results on Feb 23, 2027Croda International Plc announced that they will report fiscal year 2026 results on Feb 23, 2027お知らせ • Oct 17Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025Croda International Plc provided earnings guidance for the fourth quarter and full year of fiscal year 2025. For the quarter, the company absolute sales in quarter 4 are likely to be seasonally lower than in the first 3 quarters as customers typically manage their working capital into the year-end. Despite this, the combination of good sales growth year-to-date and anticipated cost savings means that the company continue to expect GBP 265 million to GBP 295 million of group adjusted profit before tax at constant currency. For the full year, the company reiterated full year guidance.お知らせ • Jul 31Croda International plc Announces an Interim Dividend in Respect of 2025, Payable on 7 October 2025Croda International Plc announced an interim dividend in respect of 2025 of 48.0 pence per share, amounting to a total dividend of £67.0 million, was declared by the Directors at their meeting on 25 July 2025. This interim report does not reflect the 2025 interim dividend payable. The dividend will be paid on 7 October 2025 to shareholders registered on 29 August 2025.お知らせ • Mar 04Croda International Plc Announces Retirement of Julie Kim from the Board, Effective July 26, 2025Croda International Plc announced that Julie Kim will retire from the Board on 26 July 2025, having served four years as a non-executive director, in order to focus on her executive commitments. Julie has recently been named as the next CEO of Takeda Pharmaceutical.お知らせ • Feb 26Croda International Plc, Annual General Meeting, Apr 23, 2025Croda International Plc, Annual General Meeting, Apr 23, 2025.お知らせ • Feb 25Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2024, Payable on May 28, 2025The Directors of Croda International Plc are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2024. Subject to shareholder approval, the dividend will be paid on 28 May 2025 to shareholders registered on 11 April 2025. The total proposed dividend for the year ended 31 December 2024 will be 110 pence per share amounting to £153.5 million. The Board is proposing to increase the full year dividend to 110 pence (2023: 109 pence), despite temporarily taking company above its stated percentage of adjusted profit after tax, reflecting its confidence in delivery of future earnings growth.お知らせ • Jan 22+ 1 more updateCroda International Plc to Report Fiscal Year 2025 Results on Feb 24, 2026Croda International Plc announced that they will report fiscal year 2025 results on Feb 24, 2026お知らせ • Nov 19Croda International plc Announces Directorate ChangeCroda International Plc announced that John Ramsay, having served as a non-executive director and Chair of Audit Committee for over 5 years, will retire from the Board on 1 March 2025 and not seek re-election at the 2025 AGM (due to increased business and personal commitments). In preparation for John's retirement next year, Ian Bull will take over as Chair of the Audit Committee with effect from 1 December 2024 and so lead the Committee over Croda's 2024 year-end. Ian has been a member of the Audit Committee since his appointment to the Board on 24 June 2024. Ian is currently the Audit Committee Chair of Dunelm Group plc, Senior Independent Director at Domino's Pizza Group plc and Fellow of the Chartered Institute of Management Accountants. John will remain a member of the Audit Committee, as well as the Nomination and Remuneration Committees until his retirement from the Board.お知らせ • Jul 01+ 1 more updateStephen Oxley to Join Croda International plc as Executive Director No Later Than 1 April 2025Croda International Plc announced that the Board has appointed Stephen Oxley as Executive Director. Stephen, a qualified accountant, is currently CFO of Johnson Matthey Plc, the specialty chemicals and sustainable technologies company. Stephen brings valuable experience in strategy setting and execution, enhancing business performance, transformation and corporate transactions. Stephen was previously a Partner at KPMG where he spent nearly 30 years advising global companies across consumer, healthcare and industrial sectors. He is also a Non-Executive Member of the Audit and Risk Committee for the Sovereign Grant which oversees the UK's public grant to the Royal Family. Stephen will join Croda no later than April 1, 2025 following a notice period. Anthony Fitzpatrick,President Strategy, Corporate Development & Industrial Specialties, has been appointed Interim Chief Financial Officer. Anthony joined Croda and the Executive Committee in 2014 having previously spent more than 20 years in global investment banking.お知らせ • Jun 27Croda International Plc Appoints Ian Bull as Non-Executive Director and Member of the Audit, Nomination and Remuneration CommitteesThe Board of Croda International Plc announced the appointment of Ian Bull as a Non-Executive Director with effect from 25 June 2024. Ian has extensive experience with listed companies across a wide range of industries, both domestic and international, both as an Executive Director as well as Senior Independent Director and Audit Committee Chair. He was previously Group Finance Director of Greene King plc, Chief Financial Officer at Ladbrokes plc, and was most recently Chief Financial Officer of Parkdean Resorts Group. Ian was formerly a non-executive Director of Paypoint Ltd, Chair of Lookers plc and Senior Independent Director and Audit Committee Chair of St. Modwen Properties plc. Ian is currently a Non-Executive Director and Audit Committee Chair of Dunelm Group plc and Senior Independent Director of Domino's Pizza Group Plc. He is a Fellow of the Chartered Institute of Management Accountants. On joining the Board, Ian will be appointed to the Audit, Nomination and Remuneration Committees.お知らせ • Apr 27Croda International Plc Declares Final DividendCroda International Plc at its Annual General Meeting held on 24 April 2024 declared a final dividend of 62.0 pence per ordinary share.お知らせ • Feb 29Croda International plc Recommends Final Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 29 May 2024The Directors of Croda International Plc are recommending a final dividend of 62.0 pence per share amounting to a total of £86.5m in respect of the financial year ended 31 December 2023. Subject to shareholder approval, the dividend will be paid on 29 May 2024 to shareholders registered on 19 April 2024. The total proposed dividend for the year ended 31 December 2023 will be 109.0pper share amounting to £152.1m.お知らせ • Jan 30+ 1 more updateCroda International Plc to Report First Half, 2024 Results on Jul 30, 2024Croda International Plc announced that they will report first half, 2024 results on Jul 30, 2024お知らせ • Dec 20Croda International plc Announces Louisa Burdett, Chief Financial Officer, Intends to Leave in June 2024Croda International Plc announced that Louisa Burdett, Chief Financial Officer, intends to leave the Company in June 2024 to become Chief Financial Officer at Spirax-Sarco Engineering plc.お知らせ • Dec 19Croda International plc Announces Resignation of Louisa Burdett from BoardCroda International Plc announced that Louisa Burdett, Non-Executive Director, will leave the board in June 2024.お知らせ • Sep 22+ 1 more updateCroda International Plc, Annual General Meeting, Apr 24, 2024Croda International Plc, Annual General Meeting, Apr 24, 2024.お知らせ • Jul 06Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370).Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW 350 billion on February 3, 2023. The acquisition is subject to regulatory approval. Lazard & Co., Limited acted as financial advisor to Croda International Plc (LSE:CRDA).Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) on July 4, 2023. The acquisition comes following receipt of unconditional approval from the South Korean regulatory authorities.お知らせ • Feb 07Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion.Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion on February 6, 2023. The acquisition is subject to regulatory approval.お知らせ • Mar 04Croda International Plc to Report Fiscal Year 2022 Results on Mar 07, 2023Croda International Plc announced that they will report fiscal year 2022 results on Mar 07, 2023収支内訳Croda International の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:COIH.F 収益、費用、利益 ( )GBP Millions日付収益収益G+A経費研究開発費31 Dec 251,69962629030 Sep 251,684101569030 Jun 251,668140508031 Mar 251,648149505031 Dec 241,628159502030 Sep 241,629161502030 Jun 241,630163503031 Mar 241,662167490031 Dec 231,695171477030 Sep 231,769182492030 Jun 231,843194507031 Mar 231,966422523031 Dec 222,089649539030 Sep 222,086680523030 Jun 222,083711508031 Mar 221,986516504031 Dec 211,890321501030 Sep 211,771284453030 Jun 211,651247406031 Mar 211,521224369031 Dec 201,390202332030 Sep 201,363204321030 Jun 201,336207311031 Mar 201,357216311031 Dec 191,378224311030 Sep 191,388230279030 Jun 191,399235247031 Mar 191,393237219031 Dec 181,387239191030 Sep 181,378241192030 Jun 181,369244193031 Mar 181,371241194031 Dec 171,373237194030 Sep 171,358226190030 Jun 171,342214187031 Mar 171,293206174031 Dec 161,244197162030 Sep 161,185192148030 Jun 161,126187134031 Mar 161,104184127031 Dec 151,082181119030 Sep 151,078178118030 Jun 151,0741751180質の高い収益: COIH.Fは 高品質の収益 を持っています。利益率の向上: COIH.Fの現在の純利益率 (3.6%)は、昨年(9.7%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: COIH.Fの収益は過去 5 年間で年間22.1%減少しました。成長の加速: COIH.Fは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: COIH.Fは過去 1 年間で収益成長率がマイナス ( -60.9% ) となったため、 Chemicals業界平均 ( -1.4% ) と比較することが困難です。株主資本利益率高いROE: COIH.Fの 自己資本利益率 ( 2.9% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/17 06:49終値2026/04/29 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Croda International Plc 13 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。33 アナリスト機関James KnightBarclaysKatie RichardsBarclaysAmy LianBarclays30 その他のアナリストを表示
お知らせ • Dec 24+ 1 more updateCroda International Plc to Report Fiscal Year 2026 Results on Feb 23, 2027Croda International Plc announced that they will report fiscal year 2026 results on Feb 23, 2027
お知らせ • Jan 22+ 1 more updateCroda International Plc to Report Fiscal Year 2025 Results on Feb 24, 2026Croda International Plc announced that they will report fiscal year 2025 results on Feb 24, 2026
お知らせ • Jan 30+ 1 more updateCroda International Plc to Report First Half, 2024 Results on Jul 30, 2024Croda International Plc announced that they will report first half, 2024 results on Jul 30, 2024
お知らせ • Mar 04Croda International Plc to Report Fiscal Year 2022 Results on Mar 07, 2023Croda International Plc announced that they will report fiscal year 2022 results on Mar 07, 2023
お知らせ • Apr 25Croda International plc Approves Final DividendCroda International Plc at its AGM held on April 22, 2026 approved a final dividend of 63.0 pence per ordinary share.
お知らせ • Feb 25Croda International Plc, Annual General Meeting, Apr 22, 2026Croda International Plc, Annual General Meeting, Apr 22, 2026.
お知らせ • Feb 24Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2025, Payable on 27 May 2026Croda International Plc announced that the Directors are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2025. Subject to shareholder approval, the dividend will be paid on 27 May 2026 to shareholders registered on 10 April 2026. The total proposed dividend for the year ended 31 December 2025 will be 111 pence per share amounting to £154.9 million.
お知らせ • Jan 09Croda International Plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026Croda International Plc announced the appointment of Jill Anderson as a Non-Executive Director. Jill will join the Board on January 12, 2026 and become a member of the Audit, Nomination and Remuneration Committees. Jill brings more than 30 years' experience in international leadership positions in the healthcare industry, including executive responsibility in finance, commercial research and supply chain functions. Most recently, Jill was Chief Financial Officer of GSK's R&D division until she retired in 2024. Jill is currently a Non-Executive Director and Audit Committee Chair at Spire Healthcare Group plc.
お知らせ • Dec 24+ 1 more updateCroda International Plc to Report Fiscal Year 2026 Results on Feb 23, 2027Croda International Plc announced that they will report fiscal year 2026 results on Feb 23, 2027
お知らせ • Oct 17Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025Croda International Plc provided earnings guidance for the fourth quarter and full year of fiscal year 2025. For the quarter, the company absolute sales in quarter 4 are likely to be seasonally lower than in the first 3 quarters as customers typically manage their working capital into the year-end. Despite this, the combination of good sales growth year-to-date and anticipated cost savings means that the company continue to expect GBP 265 million to GBP 295 million of group adjusted profit before tax at constant currency. For the full year, the company reiterated full year guidance.
お知らせ • Jul 31Croda International plc Announces an Interim Dividend in Respect of 2025, Payable on 7 October 2025Croda International Plc announced an interim dividend in respect of 2025 of 48.0 pence per share, amounting to a total dividend of £67.0 million, was declared by the Directors at their meeting on 25 July 2025. This interim report does not reflect the 2025 interim dividend payable. The dividend will be paid on 7 October 2025 to shareholders registered on 29 August 2025.
お知らせ • Mar 04Croda International Plc Announces Retirement of Julie Kim from the Board, Effective July 26, 2025Croda International Plc announced that Julie Kim will retire from the Board on 26 July 2025, having served four years as a non-executive director, in order to focus on her executive commitments. Julie has recently been named as the next CEO of Takeda Pharmaceutical.
お知らせ • Feb 26Croda International Plc, Annual General Meeting, Apr 23, 2025Croda International Plc, Annual General Meeting, Apr 23, 2025.
お知らせ • Feb 25Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2024, Payable on May 28, 2025The Directors of Croda International Plc are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2024. Subject to shareholder approval, the dividend will be paid on 28 May 2025 to shareholders registered on 11 April 2025. The total proposed dividend for the year ended 31 December 2024 will be 110 pence per share amounting to £153.5 million. The Board is proposing to increase the full year dividend to 110 pence (2023: 109 pence), despite temporarily taking company above its stated percentage of adjusted profit after tax, reflecting its confidence in delivery of future earnings growth.
お知らせ • Jan 22+ 1 more updateCroda International Plc to Report Fiscal Year 2025 Results on Feb 24, 2026Croda International Plc announced that they will report fiscal year 2025 results on Feb 24, 2026
お知らせ • Nov 19Croda International plc Announces Directorate ChangeCroda International Plc announced that John Ramsay, having served as a non-executive director and Chair of Audit Committee for over 5 years, will retire from the Board on 1 March 2025 and not seek re-election at the 2025 AGM (due to increased business and personal commitments). In preparation for John's retirement next year, Ian Bull will take over as Chair of the Audit Committee with effect from 1 December 2024 and so lead the Committee over Croda's 2024 year-end. Ian has been a member of the Audit Committee since his appointment to the Board on 24 June 2024. Ian is currently the Audit Committee Chair of Dunelm Group plc, Senior Independent Director at Domino's Pizza Group plc and Fellow of the Chartered Institute of Management Accountants. John will remain a member of the Audit Committee, as well as the Nomination and Remuneration Committees until his retirement from the Board.
お知らせ • Jul 01+ 1 more updateStephen Oxley to Join Croda International plc as Executive Director No Later Than 1 April 2025Croda International Plc announced that the Board has appointed Stephen Oxley as Executive Director. Stephen, a qualified accountant, is currently CFO of Johnson Matthey Plc, the specialty chemicals and sustainable technologies company. Stephen brings valuable experience in strategy setting and execution, enhancing business performance, transformation and corporate transactions. Stephen was previously a Partner at KPMG where he spent nearly 30 years advising global companies across consumer, healthcare and industrial sectors. He is also a Non-Executive Member of the Audit and Risk Committee for the Sovereign Grant which oversees the UK's public grant to the Royal Family. Stephen will join Croda no later than April 1, 2025 following a notice period. Anthony Fitzpatrick,President Strategy, Corporate Development & Industrial Specialties, has been appointed Interim Chief Financial Officer. Anthony joined Croda and the Executive Committee in 2014 having previously spent more than 20 years in global investment banking.
お知らせ • Jun 27Croda International Plc Appoints Ian Bull as Non-Executive Director and Member of the Audit, Nomination and Remuneration CommitteesThe Board of Croda International Plc announced the appointment of Ian Bull as a Non-Executive Director with effect from 25 June 2024. Ian has extensive experience with listed companies across a wide range of industries, both domestic and international, both as an Executive Director as well as Senior Independent Director and Audit Committee Chair. He was previously Group Finance Director of Greene King plc, Chief Financial Officer at Ladbrokes plc, and was most recently Chief Financial Officer of Parkdean Resorts Group. Ian was formerly a non-executive Director of Paypoint Ltd, Chair of Lookers plc and Senior Independent Director and Audit Committee Chair of St. Modwen Properties plc. Ian is currently a Non-Executive Director and Audit Committee Chair of Dunelm Group plc and Senior Independent Director of Domino's Pizza Group Plc. He is a Fellow of the Chartered Institute of Management Accountants. On joining the Board, Ian will be appointed to the Audit, Nomination and Remuneration Committees.
お知らせ • Apr 27Croda International Plc Declares Final DividendCroda International Plc at its Annual General Meeting held on 24 April 2024 declared a final dividend of 62.0 pence per ordinary share.
お知らせ • Feb 29Croda International plc Recommends Final Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 29 May 2024The Directors of Croda International Plc are recommending a final dividend of 62.0 pence per share amounting to a total of £86.5m in respect of the financial year ended 31 December 2023. Subject to shareholder approval, the dividend will be paid on 29 May 2024 to shareholders registered on 19 April 2024. The total proposed dividend for the year ended 31 December 2023 will be 109.0pper share amounting to £152.1m.
お知らせ • Jan 30+ 1 more updateCroda International Plc to Report First Half, 2024 Results on Jul 30, 2024Croda International Plc announced that they will report first half, 2024 results on Jul 30, 2024
お知らせ • Dec 20Croda International plc Announces Louisa Burdett, Chief Financial Officer, Intends to Leave in June 2024Croda International Plc announced that Louisa Burdett, Chief Financial Officer, intends to leave the Company in June 2024 to become Chief Financial Officer at Spirax-Sarco Engineering plc.
お知らせ • Dec 19Croda International plc Announces Resignation of Louisa Burdett from BoardCroda International Plc announced that Louisa Burdett, Non-Executive Director, will leave the board in June 2024.
お知らせ • Sep 22+ 1 more updateCroda International Plc, Annual General Meeting, Apr 24, 2024Croda International Plc, Annual General Meeting, Apr 24, 2024.
お知らせ • Jul 06Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370).Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW 350 billion on February 3, 2023. The acquisition is subject to regulatory approval. Lazard & Co., Limited acted as financial advisor to Croda International Plc (LSE:CRDA).Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) on July 4, 2023. The acquisition comes following receipt of unconditional approval from the South Korean regulatory authorities.
お知らせ • Feb 07Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion.Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion on February 6, 2023. The acquisition is subject to regulatory approval.
お知らせ • Mar 04Croda International Plc to Report Fiscal Year 2022 Results on Mar 07, 2023Croda International Plc announced that they will report fiscal year 2022 results on Mar 07, 2023